Matthias P.
- Country
- Germany
- Department
- Klinik für Neurologie
Research Overview
- Evaluation of Safety and Efficacy of PRI-002 in Patients with Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
- Efficacy and Safety Evaluation of Mirodenafil Dihydrochloride in Early Alzheimer's Disease: A Phase 3 Double-Blind, Randomized, Placebo-Controlled Trial
- Evaluation of RO7269162 on Amyloid Biomarkers in Prodromal Alzheimer's Disease: A Phase IIa Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 138 of 264 partner sites.
Specializations
Neurodegenerative Disorders
This investigator specializes in the treatment and research of neurodegenerative conditions, with a primary focus on various stages of Alzheimer's disease, from preclinical to early manifestations.
- Early Alzheimer's Disease
- Preclinical Alzheimer's Disease
- Mild Cognitive Impairment (MCI)
- Amyotrophic Lateral Sclerosis (ALS)
Their research encompasses innovative therapeutic approaches for managing cognitive decline and neurological progression.
Cognitive Function
The investigator focuses on evaluating cognitive decline and developing treatments to address memory and cognitive function in neurological conditions.
- Cognitive Assessment Methods
- Dementia Management
- Clinical Dementia Rating
- Cognitive Performance Measures
Their work includes comprehensive assessment of cognitive outcomes in neurodegenerative disorders.
Therapeutic Innovations
The investigator explores novel therapeutic approaches including immunotherapy and targeted treatments for neurodegenerative conditions.
- Active Immunotherapy
- Tau-Targeted Treatments
- Disease-Modifying Therapies
- Experimental Therapeutics
Their research involves evaluating emerging treatments for various stages of neurological disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.